Denmark’s Leo Pharma Delays IPO Plans Beyond 2026, CEO Says
Bloomberg Markets
16 lis 2026, 10:22Crypto
1 min read
Denmark's Leo Pharma A/S is delaying its initial public offering plans beyond 2026, pushing back a listing previously targeted for this year.
The Danish pharmaceutical company had originally planned to go public in 2026 but has now extended that timeline indefinitely. No specific reasons for the delay were provided in the announcement.
Related
Article written by AI
Z.ai GLM-4.5-FlashFree